Thalassaemia trials in Lebanon

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Where

  Hamra, Hazmiyeh, Tripoli

  Age

  2 years and over

  People

  480 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06609226 · EU 2024-510805-27-00
• Phase 2Taking people
  Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

  Where

  Beirut

  Age

  6 years to 17 years

  People

  99 worldwide

  Run by

  Celgene

  See details and how to joinNCT04143724 · EU 2022-502499-22-00
• Phase 3Taking people
  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Where

  Hazmiyeh

  Age

  18 years and over

  People

  665 worldwide

  Run by

  Celgene

  See details and how to joinNCT04064060